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Abstract
Background: Receptor interacting protein 140 (RIP140) is a versatile transcriptional co-repressor that plays roles in diverse
metabolic processes including fat accumulation in adipocytes. Previously we identified three methylated arginine residues
in RIP140, which rendered its export to the cytoplasm; but it was unclear what triggered RIP140 arginine methylation.
Methodology/Principal Findings: In this study, we determined the activated PKCe as the specific trigger for RIP140 arginine
methylation and its subsequent export. We identified two PKCe–phosphorylated residues of RIP140, Ser-102 and Ser-1003,
which synergistically stimulated direct binding of RIP140 by 14-3-3 that recruited protein arginine methyl transferase 1 to
methylate RIP140. The methylated RIP140 then preferentially recruited exportin 1 for nuclear export. As a result, the nuclear
gene-repressive activity of RIP140 was reduced. In RIP140 null adipocyte cultures, the defect in fat accumulation was
effectively rescued by the phosphoylation-deficient mutant RIP140 that resided predominantly in the nucleus, but less so by
the phospho-mimetic RIP140 that was exported to the cytoplasm.
Conclusions/Significance: This study uncovers a novel means, via a cascade of protein modifications, to inactivate, or
suppress, the nuclear action of an important transcription coregulator RIP140, and delineates the first specific
phosphorylation-arginine methylation cascade that could alter protein subcellular distribution and biological activity.
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Introduction
Receptor-interacting protein 140 (RIP140) also known as NRIP1
(Nuclear Receptor Interacting Protein 1) is a versatile co-repressor
for nuclear receptors and many transcription factors and contains
several autonomous repressive domains [1–5]. RIP140 is known to
play important roles in adipocyte and hepatocyte function [6–7],
energy homeostasis [8] and reproduction [9], as well as a wide
spectrum of metabolic pathways such as glucose uptake, glycolysis,
TCA cycle, fatty acid oxidation, mitochondrial biogenesis and
oxidative phosphorylation, etc. [10]. In RIP140-null mice, a
repertoire of genes were found to be abnormally expressed [6,11].
Our recent endeavors further uncovered extensive post-translational
modifications (PTMs) of RIP140, which not only altered the
property and function of RIP140 but also triggered its specific
subcellular translocation [5,12].
Established PTMs of RIP140 include phosphorylation [4,13],
acetylation [14], methylation [12] and pyridoxal 59-phosphate
(PLP) conjugation [15]. All these PTMs affect the biological
activity of RIP140. Of particular significance is protein arginine
methyl transferase (PRMT)-mediated arginine methylation on
three specific arginine residues of RIP140, Arg240, 650, 948,
which negatively regulates its biological activity in the nucleus
(gene repression) by reducing its interaction with a corepressive
enzyme machinery containing HDAC3 and facilitating its export
to the cytoplasm via the exportin (CRM1)-containing export
machinery [12]. As a result, the nuclear, gene repressive, activity
of RIP140 is reduced.
Some of the extracellular cues/stimuli for phosphorylation,
acetylation and pyridoxylation of RIP140 have begun to be
investigated, but it was unclear what triggered protein arginine
methylation of RIP140 to stimulate its nuclear export. In
particular, the signals for this important PTM in the context of
adipocyte differentiation, where the physiological role of RIP140
has been clearly established, was most interesting. The primary
goals of this study were to identify the signal(s) that stimulated
arginine methylation of RIP140 in adipocyte differentiation, and
to delineate the signal transduction pathway that transmitted the
stimuli and ultimately rendered the export of RIP140 to the
cytoplasm.
It was first found that protein kinase C epsilon (PKCe)-
stimulated phosphorylation of RIP140 also reduced its gene
repressive activity by triggering its export to the cytoplasm. The
targets of PKC action on RIP140 were located to two specific
serine residues, Ser-102 and 1003, both of which were critical for
its arginine methylation and nuclear export. This was mediated by
the recruitment of chaperone 14-3-3/PRMT1 complex to the
PKC-phosphorylated RIP140 and the action of PRMT1 to
methylate RIP140. In differentiating cultures, the expression and
activity of PKCe was elevated, which triggered this cascade of
events. Further, the physiological relevance of this signal
transduction pathway, that altered the PTMs of RIP140 and its
PLoS ONE | www.plosone.org 1 July 2008 | Volume 3 | Issue 7 | e2658subcellular localization and activity, was demonstrated in gain-
and loss-function studies using specific point mutations, as well as
wild type and RIP140 null adipocyte cultures.
Results
PKC-stimulated phosphorylation at Ser-102 and Ser-1003
of RIP140 regulates its cytoplasmic localization
In our previous study, [12] we have established the export of
RIP140 to the cytoplasm, which was stimulated by its specific
arginine methylation.Toexamine the upstream signaling eventsthat
triggered the export of RIP140, a preliminary study was conducted
by using pharmacological agents. These tests revealed that
compounds that regulated PKC activities could modulate the
nucleo-cytoplasmic translocation of endogenous RIP140 in differ-
entiating (8 days) adipocyte cultures (Figure 1A). A fraction of
endogenous RIP140 appeared in the cytoplasm of the normally
differentiating culture (lane 1, control), and a significantly increased
cytoplasmic RIP140 was detected when the PKC pathway of the
culture was further stimulated (lane 2). Conversely, RIP140
remained, primarily, nuclear when the PKC pathway was blocked
(lane 3). An RNAi experiment to knock down endogenous RIP140
was included for a control (lane 4). In agreement with PKC-
stimulated cytoplasmic localization of RIP140, the known biological
activity of nuclear RIP140, gene repression, was inhibited by PKC
but not MAPK(anegativecontrol)(Figure 1B). Furtheritwas the N-
and C-termini, but not the central domain, of RIP140 that
responded to the activation of PKC (Figure S1A).
To identify residues responsive to PKC activation, we extended
our previous proteomic endeavor that has revealed eleven
phosphorylated sites on RIP140 [4,13] and uncovered one
additional phosphorylated residue at Ser-102 (Figure S2). Since
both the N- and the C-termini, but not the central domain,
responded to PKC activation, we then screened all the
phosphorylated residues in these two domains, including residues
at 102, 104, 202, 207, 358, 380 (for the N-terminus) and a single
phosphorylated residue at 1003 (for the C-terminus) by mutations
mimicking constitutive dephosphorylation (CN, S/TRA). This
series of mutation studies identified Ser-102 and Ser-1003 as the
critical residues responsive to PKC activation (Figure S1B). The
functional roles of these two residues, with respect to gene
repression, were further verified by incorporating either the
constitutive negative (dephosphorylation, CN, SRA) or the
phospho-mimetic (CP, SRE) [4,16] mutation in the context of
the full-length protein. (Figure 1C). It appeared that while each
single mutation of 102, or 1003, exerted a partial effect, only the
double mutation (of Ser-102 and Ser-1003) could completely
abrogate the responsiveness to PKC activation, indicating
synergistic effects of phosphorylation at these two specific residues.
The double negative mutant (102CN+1003CN) was strongly
repressive, whereas the double phospho-mimetic mutant
(102CP+1003CP) was not effective in trans-repression. A mock
mutation at Ser-315, a negative control, exerted no effect on the
repressive activity of RIP140.
We then validated the effects of phosphorylation of Ser-102 and
Ser-1003 on subcellular distribution of RIP140 in reconstituted
RIP140 null adipocyte cultures. While the individual mutation,
either Ser-102 or Ser-1003, slightly affected the nuclear/
cytoplasmic distribution of RIP140, only the double mutant
exhibited a more pronounce effect (Figure 1D). The double
negative (D-CN) mutant was retained, almost entirely, in the
nucleus whereas the double phospho-mimetic mutant (D-CP) was
increasingly cytoplasmic. This was in agreement with the result of
their trans-repressive activity shown in Figure 1C.
PKC-phosphorylated RIP140 is associated with 14-3-3 and
PRMT1 and is methylated at arginine residues
In our previous study we identified three methylated arginine
residues on RIP140, which stimulated its export to the cytoplasm
[12]. A separate study from another group has implicated 14-3-3
dependent intracellular relocalization of RIP140 in the cytoplasm
[17]. It was known that 14-3-3 and PRMT1 could directly interact
with multiple common partners such as DAL-1 [18–19], p53 [20–
21], and histone 4 [22–23]; therefore, 14-3-3 and PRMT1 could
possibly exist in the same molecular complex. We thus speculated
if PKC-stimulated phosphorylation of RIP140 could trigger its
physical association with the 14-3-3/PRMT1 complex, thereby
rendering its arginine methylation (Figure 2A). Very interestingly,
in differentiated adipocyte cultures, a basal methylation level of
endogenous RIP140 was detected in the absence of any external
stimuli, supporting the presence of an autonomous signaling
pathway in the differentiating adipocyte culture for arginine
methylation of RIP140 (Figure 2A top panel, lane1). While
additional MAPK stimulation (lane 2) did not significantly affect
the methylation status of RIP140, additional PKC activation was
able to enhance (lane 4), and inhibition of PKC reduced (lane 5),
the level of arginine methylation of endogenous RIP140.
Consistently, complex formation of RIP140/PRMT1, and of
RIP140/14-3-3, was significantly enhanced by a PKC activator
and reduced by a PKC inhibitor (2
nd and 3
rd panels). The
formation of the tri-molecular complex was then verified by
sequential IP experiments where the RIP140/PRMT1 or
RIP140/14-3-3 immuno-complex was subsequently examined to
determine its association with the third partner, 14-3-3 or PRMT1
(4
th and 5
th panels). These results, all together, demonstrated PKC
activation-stimulated tri-molecular complex formation of endog-
enous RIP140/14-4-3/PRMT1 in differentiating adipocyte cul-
ture, which rendered arginine methylation of RIP140.
It was known that the export of RIP140, as stimulated by
PRMT1 mediated methylation, involved a down stream effecter,
the exportin (CRM1) [12]. In order to determine if PKC-triggered
export of RIP140 could also be attributed to the action of exportin
CRM1, a selective inhibitor of CRM1-mediated export, leptomy-
cin B, [24] was used. As shown in Figure 2B lane 2, arginine
methylation of RIP140, as well as its cytoplasmic distribution, was
increased by the activation of PKC. Leptomycin B significantly
hindered PKC-stimulated export of RIP140, with methylated
RIP140 accumulated in the nucleus (lane 4), suggesting that PKC-
activated export of RIP140 employed the same CRM1-mediated
export machinery.
The PKC-triggered phosphorylation-methylation cascade and
its associated effector molecules were then validated in RIP140
null adipocytes rescued by expressing either the dominant negative
(D-CN) or the double phospho-mimetic (D-CP) mutant RIP140.
The wild type RIP140 was methylated, and was able to interact
with PRMT1 and 14-3-3 at a basal level. For the phospho-mimetic
RIP140, methylation was enhanced and its association with 14-3-3
and PRMT1 was also increased. On the contrary, the dominant
negative mutant failed to be methylated and could not be
associated with PRMT1 or 14-3-3 (Figure 2C). In agreement with
the methylation status of RIP140, which is a key actor regulating
cellular distribution of RIP140 [12], the gene-repressive (nuclear
activity) effect of the wild type and the mutant RIP140 on one of
the endogenous target genes, RAR-b2, was verified as shown in
Figure 2C (the 2
nd panel from the bottom). The wild type (WT),
and the dominant negative (D-CN) RIP140 which was predom-
inantly nuclear in localization, repressed basal expression of RAR-
b2; whereas the double phospho-mimetic (D-CP) RIP140, which
would be primarily cytoplasmic, did not elicit such a nuclear
Nuclear-Cytoplasmic of RIP140
PLoS ONE | www.plosone.org 2 July 2008 | Volume 3 | Issue 7 | e2658Figure 1. Effect of PKC phosphorylation on subcellular localization of RIP140. (A) Cellular distribution of endogenous RIP140 in
differentiated adipocyte cultures where PKC activity was pharmacologically activated (PMA) or inactivated (Calphostin C). The results were obtained
in cell fractionation studies (left) and immunocytochemistry (right). (B) PMA (PKC-Ac) reduced nuclear trans-repressive activity of RIP140. (C) Ser-102
and Ser-1003, residues mediated, synergistically, the effect of PKC on trans-repressive activity of RIP140. (D) Sub-cellular distribution of single/double
constitutive negative (CN)/phospho-mimetic (CP) mutants. D-CN: double constitutive negative mutant; D-CP: double constitutive (phospho-mimetic)
mutant.
doi:10.1371/journal.pone.0002658.g001
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PLoS ONE | www.plosone.org 3 July 2008 | Volume 3 | Issue 7 | e2658Figure 2. Effects of PKC-mediated phosphorylation on RIP140 interaction with the export effectors. (A) PKC, but not MAPK, activation
induced in vivo hypermethylation and association of endogenous RIP140 with the effecter molecules 14-3-3 and PRMT1. (B) Leptomycin B (LMB), a
specific inhibitor of CRM1, blocked PKC triggered export of RIP140 without affecting its methylation status. (C) D-CP, but not D-CN, RIP140 was
methylated and associated with the effecter molecules 14-3-3 and PRMT in RIP140 null adipocytes. The nuclear activity of the WT, D-CN, D-CP RIP140
was verified by examining the repression of its endogenous target RAR-b2 detected on a western blot. (D) A methylation inhibitor (MTI) blocked the
export of D-CP RIP140.
doi:10.1371/journal.pone.0002658.g002
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mimetic RIP140 was important for its export by using adenosine-
2,3-dialdehyde, a global methyl transferase inhibitor (MTI), in this
system. This methylation inhibitor abrogated the methylation and
export of the phospho-mimetic RIP140 (Figure 2D, lane 4),
supporting arginine methylation as the down stream mediator of
PKC phosphorylation-stimulated export of RIP140.
14-3-3 chaperone facilitates the recruitment of PRMT1 to
RIP140 for its methylation and export
Ser-102 and 1003 were the principal targets of PKC that
modulated the association of RIP140 with 14-3-3/PRMT1
(Figure 2). Ser-1003 is in close proximity to a consensus site for
14-3-3 binding, and Ser-102 is within an imperfect site for 14-3-3
binding (Table 1). Because RIP140 did not directly interact with
PRMT1 [12], we thus speculated a role for 14-3-3 in mediating
the formation of RIP140/14-3-3/PRMT1 tri-molecular complex.
A GST-pull down assay was first employed to examine the
potential direct interaction of 14-3-3 with RIP140 (Figure 3A).
The bacterially produced wild type (WT) RIP140, as well as
negative phospho-mutants (102CN and 1003CN single mutants
and the double mutant D-CN), failed to interact with 14-3-3.
Importantly, two single phospho-mimetic mutants (102CP and
1003CP) apparently interacted directly with 14-3-3; further, the
double phospho-mimetic RIP140 (D-CP) even more strongly
interacted with 14-3-3. This result clearly showed that while the
dephosphorylated (at two PKC sites, residues 102 and 1003)
RIP140 could not directly interact with 14-3-3, phosphorylation at
these two sites indeed facilitated direct interaction of RIP140 with
14-3-3.
The results thus far have suggested a signaling pathway,
initiated from the activated PKC that triggered RIP140 phos-
phorylation at residues 102 and 1003, stimulated RIP140’s direct
interaction with (or recruitment of) 14-3-3, which could scaffold
PRMT1. The recruited PRMT1 then acted on RIP140 to
methylate three arginine residues [12], resulting in the export of
methylated RIP140. It has been reported that in differentiated
adipocytes, PKCe was the principal functional PKC [25–27],
which had also been detected in our experimental system. A
knockdown approach was then employed to validate the
speculated functional roles of the key factors in this pathway,
PKCe, 14-3-3 and PRMT1 (Figure 3B). The results showed that
knockdown of any one of these three factors indeed drastically
reduced methylation (the 1st panel) and export (the 8
th panel) of
RIP140, confirming the functional roles for these factors in this
signal transduction pathway. Further, knockdown of PKCe
abrogated the association of RIP140 with 14-3-3 (the 2
nd panel)
and PRMT1 (the 3
rd panel). Very interestingly, while knockdown
of 14-3-3 reduced the association of RIP140 with PRMT1 (the 3
rd
panel), knockdown of PRMT1 had no effect on the association of
RIP140 with 14-3-3 (the 2
nd panel). These results supported a
hierarchy of events initiated from PKCe-mediated phosphoryla-
tion, which triggered the recruitment of 14-3-3 that could scaffold
PRMT1 to methylate RIP140, thereby stimulating its subsequent
nuclear export.
Kinetics of changing factors stimulating arginine
methylation of RIP140 in differentiating adipocytes
To examine the changing cellular factors leading to ultimate
arginine methylation of RIP140 in differentiating adipocyte culture,
the kinetics of the expression and/or activation of relevant
endogenous factors, as well as the nuclear/cytoplasmic distribution
of these components and RIP140 in differentiating adipocyte culture
were examined as shown inFigure 4A.As expected, RIP140 was not
detected in the undifferentiated pre-adipocyte culture, readily
appeared in the nucleus at the first time point examined (day 3)
and then was detected in the cytoplasm at the second time point
examined (day 6) of the differentiating culture (top panel). The
expression of PKCe was clearly detected at day 6 of differentiation
and steadily increased (2
nd panel). PKCe migrated on SDS/PAGE
predominantly as a doublet with molecular masses of 87 kDa and
95 kDa (PKCe
87 and PKCe
95, respectively) [28]. While the nuclear
fraction associated PKCe corresponded to PKCe
95 (2
nd, left panel),
the cytoplasmic PKCe was, primarily, PKCe
87 (2
nd, right panel). We
have also verified the activity of nuclear PKCe in vitro (see the
following, Figure4Band Figure S3). Regarding 14-3-3b, others have
shown its expression in adipocytes [29]. Interestingly while 14-3-3b
was detected in both the nucleus and the cytoplasm of the
differentiating culture (3
rd panel), it was associated with RIP140
only in the nucleus (4
th panel). PRMT1 was restricted to the nucleus
as also shown in a previous report [30] (5
th panel) and was associated
with RIP140 in the nucleus (6
th panel). The overall kinetics of the
associationofRIP140with14-3-3(4
thpanel)andPRMT1(6
thpanel)
agreed with that ofPKCe activation inthis experimentalsystem, and
was in line with the kinetics of arginine methylation of RIP140 (7
th
panel), and ultimately its export (top panel).
PKCe was found to be the principal functional isoform of
PKC expressed in the later stages during adipocyte differenti-
ation [25–27]. To verify the enzyme activity of PKCe on
RIP140, an in vitro phosphorylation assay was conducted
( F i g u r e4 B ) .W h i l et h ew i l dt y p eR I P 1 4 0e x p r e s s e di nb a c t e r i a
could be phosphorylated by the partially purified endogenous
PKCe collected from differentiating adipocytes (lane 2), the
dominant negative (CN) RIP140 and the PKC phospho-mimetic
(CP) RIP140 were only marginally phosphorylated, supporting
Ser-102 and 1003 as the principal targets of PKCe mediated
phosphorylation. This was consistent with the response of these
mutants to PKC activation shown previously (Figure 1B & C,
Figure S1). To verify the activity of PKCe in the nuclear and
cytoplasmic fractions, an in vitro phosphorylation assay was
conducted using partially purified PKCe isolated from either the
nuclear or the cytoplasmic fraction of differentiating adipocyte
culture that was further activated in vitro by PMA (Figure S3).
While PKCe from the nuclear fraction was able to readily
phosphorylate RIP140 even without in vitro activation by PMA,
the principal cytoplasmic PKCe (PKCe
87)r e q u i r e din vitro
activation by PMA to act on RIP140, supporting the notion
that PKCe
95 in the nuclear fraction, but not the cytoplasmic
Table 1. PKC responsive sites of RIP140 and their consensus
motif-specific chaperones.
Residue Sequence
a Kinase/chaperone
b
Ser-102 KRKRLSDSIVN PKC, 14-3-3 ?
Ser-1003 DHRTFSYPGMV PKC, 14-3-3
Twelve phosphorylation sites of RIP140 purified from insect cell cultures have
been identified by LC-ESI-MS/MS analysis. Ser-102 in N-terminal and Ser-1003 in
C-terminal are consensus and responsive to PKC and 14-3-3 binding.
aSequences adjoining to the residues were compared to consensus motifs of
known kinases/chaperone.
bPKC: S/T-X-K/R, K/R-X-X-S/T, K/R-X-S/T; 14-3-3: R(S)X1,2pSX(P), RXX(pS/pT)XP
and RXFX(pS/pT)XP where S, T, K, R, and P are single-letter codes of amino
acids, and X can be any amino acid. Small case p refers to phosphorylation at
respective residue.
doi:10.1371/journal.pone.0002658.t001
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87, was catalytically active in these cells [28]. This could be
attributed to the available cofactors DAG and phosphatidylser-
ine in the nuclear/perinuclear region [28,31–32] but not in the
cytoplasm. This result confirmed the phosphorylation of RIP140
by the functional PKCe in the nuclear or perinuclear regions,
leading to the subsequent signaling cascade that ultimately
triggered the export of RIP140.
Physiological relevance of PKCe activated RIP140
phosphorylation and its export with regards to fat
accumulation in differentiated adipocytes
RIP140 was shown to be important for fat accumulation in
adipocytes [6,33], and its biological activity was attributed,
primarily, to its effect on gene regulation, a nuclear event. The
signals leading to its cytoplasmic export would likely reduce, or
terminate, this nuclear effect, and possibly negatively regulated fat
accumulation in differentiating or differentiated adipocytes. To test
this hypothesis in the RIP140 null background, gain-of-function
experiments were carried out as shown in Figure 5A. Re-
expressing a wild type RIP140 (WT) effectively rescued the defect
of fat accumulation in the knockout culture (Figure 5A, bar 2), but
re-expressing the phospho-mimetic RIP140 (D-CP which could be
exported) failed to efficiently rescue this defect (Figure 5B, bar 3).
As predicted, re-expressing the phosphorylation mutant (D-CN
which would be mostly nuclear) (Figure 5B, bar 4) rescued the
defect as efficiently as the wild type RIP140. We also conducted
loss- and gain-of-function studies of PKCe in the differentiating
adipocyte culture (Figure 5B). As compared to the level of relatively
efficient fat accumulation in the wild type culture, a further increase
in fat accumulation was indeed detected in the culture with its
endogenous PKCe silenced (Figure 5A, bar 2). Consistent with the
result of studies of RIP140 gene knockout, knockdown of RIP140
also led to a significantly reduced level of fat accumulation
(Figure 5A, bar 3). This result supported a physiological relevance
of PKCe-triggered phosphorylation in the nuclear-cytoplasmic
export of RIP140, which negatively regulated fat accumulation in
differentiating or differentiated adipocytes.
Figure 3. Functional roles of PKCe, 14-3-3 and PRMT1 in RIP140 export. (A) Direct interaction (GST pull down assay) of various GST-RIP140
wild-type/mutants with 14-3-3. D-CP mutant RIP140 (phospho-mimetic mutation on Ser-102 and Ser-1003) interacted strongly with 14-3-3. (B) Loss of
function (RNA interference) of key molecules PKCe, 14-3-3b and PRMT1 in differentiating adipocyte cultures. A hierarchy of events involving PKCe
phosphorylation of RIP140, direct binding of 14-3-3, and recruitment of PRMT1 to RIP140 for its subsequent methylation and export.
doi:10.1371/journal.pone.0002658.g003
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This study extends our previously reported finding of arginine
methylation on RIP140 that triggers its export to the cytoplasm in
differentiating adipocytes, and provides mechanistic insights into
the signal that triggers the activation of a specific pathway that
ultimately leads to the action of PRMT1 to methylate RIP140. We
establish the activated PKCe in differentiating adipocytes as the
initial nuclear trigger that stimulates phosphorylation on two
specific residues of nuclear RIP140 (on Ser-102 and Ser-1003),
which renders the recruitment of a specific chaperon 14-3-3 to
RIP140 in the nucleus that brings the associated PRMT1 to
RIP140, thereby methylating RIP140 and stimulating its export.
The functionality of the three major players (PKCe, 14-3-3 and
PRMT1) in this signal transduction pathway has been confirmed
in the differentiating adipocyte culture. This study reveals not only
an autonomously activated signaling pathway for post-translation-
al modifications to regulate the nuclear activity of an important
coregulator for gene expression, RIP140, but also implicates a
possibility that RIP140 may perform certain cytoplasmic functions
in differentiating or differentiated adipocytes. With regards to the
relationship of the kinetics of the signaling factors and RIP140
Figure 4. Kinetics of cellular factors stimulating RIP140 export. (A) Kinetics of the expression/distribution of the regulatory molecules PKCe,
14-3-3b and PRMT1, leading to RIP140 export in the adipocyte differentiation model. (B) In vitro phosphorylation of RIP140 (purified from bacteria) by
endogenous PKCe partially purified from differentiating adipocyte cultures.
doi:10.1371/journal.pone.0002658.g004
Nuclear-Cytoplasmic of RIP140
PLoS ONE | www.plosone.org 7 July 2008 | Volume 3 | Issue 7 | e2658Figure 5. Physiological relevance of the sub-cellular distribution of RIP140 with respect to fat accumulation in adipocytes. (A) Gain
of the nuclear (D-CN), but not the cytoplasmic RIP140 (D-CP), more effectively rescued the defect of fat accumulation in RIP140 null adipocyte
cultures. **versus* p,0.05. (B) Loss of function of PKCe (to enhance nuclear RIP140) leads to higher levels of fat accumulation in differentiated
adipocytes. **versus* p,0.05. (C) A schematic diagram depicting the signal transduction pathway of PKCe activation to the export of RIP140.
doi:10.1371/journal.pone.0002658.g005
Nuclear-Cytoplasmic of RIP140
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observed interesting kinetics of these factors that stimulate
phosphorylation and methylation of RIP140 in differentiating
preadipocyte cultures. The changes of these factors are likely a
result of cell-autonomous response in the early differentiation
process rather than the outcome of phosphorylation-methylation
of RIP140, because these factors are the upstream signals
triggering phosphorylation-methylation of RIP140. It is therefore
predicted that these factors will probably not drastically be affected
by null mutation of RIP140, or mutation at phosphorylation-
methylation of RIP140. On the contrary, the biological end point,
or the effect of phosphorylation-methylation triggered nuclear
export or RIP140, i.e. fat accumulation, indeed could be
significantly affected by mutation in the modification status of
RIP140 as shown in Figure 5A.
It is very interesting that RIP140 can be phosphorylated on at least
12 sites, but only Ser-102 and Ser-1003 are critical for the subsequent
recruitment, or binding, of RIP140 to 14-3-3. This is in agreement
with previous reports showing that the N-terminal and C-terminal
domains of RIP140 are important for 14-3-3 binding [17]. 14-3-3
mediated cytoplasmic localization has been implicated, mostly, in the
cytoplasmic retention of certain proteins [34–35], although several
reportssuggesteditsrolealsoinnuclear export[36–38]. Thiscouldbe
due to the predominantly cytoplasmic distribution of 14-3-3 detected
in certain cell types. In the adipocyte differentiation culture, 14-3-3
could be detected in both the nucleus and the cytoplasm, but its
association with RIP140 occurred only in the nucleus (Fig. 4A).
Further, 14-3-3 binding per se, i.e. without methylation (Figure 2D),
failed to stimulate cytoplasmic distribution of RIP140, suggesting an
active role for the methylation-dependent nuclear export of RIP140,
rather than 14-3-3 mediated cytoplasmic retention or sequestration,
of RIP140. It is likely that 14-3-3 serves as a chaperone to recruit
PRMT1 to the phosphorylated RIP140 in the nucleus. PRMT1
methylates RIP140 and the methylated RIP140 then recruits
exportin to mediate its nuclear export. This is in agreement with
the widely recognized role for 14-3-3 as a scaffold [17,39].
There is an absolute requirement for CRM1 to trigger RIP140
export, since the process is blocked by a selective inhibitor of
CRM1, leptomycin B (Figure 2B). Arginine methylation of
RIP140 is crucial since a PKC phospho-mimetic RIP140 (D-CP)
failed to be exported in the presence of a methylation inhibitor
(MTI) (Figure 2D). Binding by 14-3-3 is also indispensable for the
export of RIP140 (Figure 3B). Thus, the control for cytoplasmic
distribution of RIP140 involves a specific cascade of events to
ensure proper transport of RIP140 between the nucleus and the
cytoplasm. The employment of such a tightly controlled pathway
to regulate RIP140 translocation within a specific time window of
adipocyte differentiation strongly suggests certain important
cytoplasmic functions or roles for RIP140 as the differentiating
adipocyte cultures gradually change their properties.
RIP140 is a ligand dependent co-repressor of genes regulated
by hormones and is shown to play important roles in adipocyte
differentiation, in particular with regards to fat accumulation
[6,10]. Consistently, the cytoplasmic form of RIP140 (the CP
mutant) could barely rescue the defect in fat accumulation
whereas the nuclear form (the CN mutant) was fully capable of
doing so. It is quite possible that the cytoplasmic form of RIP140
could play roles in events other than the fine-tuning of fat
accumulation in differentiated adipocytes. RIP140 modulates
diverse pathways such as glucose uptake, glycolysis, TCA cycle,
fatty acid oxidation, mitochondrial biogenesis and oxidative
phosphorylation, etc [7,33]. It remains to be seen which one(s) of
this spectrum of biological processes involves the cytoplasmic
functions of RIP140.
Finally, phosphorylation has been reported to modulate
modifications like acetylation [40], SUMOylation [41] and
ubiquitination [42]. This current report is the first demonstrating
a specific phosphorylation-methylation cascade that has an
important biological consequence in differentiating adipocytes.
Materials and Methods
Plasmid constructs and site directed mutagenesis
Mouse complementary DNAs for GFP/GST/Gal4BD fused
RIP140 and GAL4-tk-luciferase reporter were as described
previously [2,4]. Constitutive negative/positive, point/sequential
mutations involving residues Ser-102, Ser-104, Thr-202, Thr-207,
Ser-315, Ser-358, Ser380 and Ser-1003 in RIP140 expression
vectors as template were made using QuikChange XL site-directed
mutagenesis kit (Stratagene). The mutagenic primers for RIP140
were designed to match alanine (A) or glutamic acid (E). S/TRA
produced a constitutively dephosphorylated state (CN), S/TRE
mimicks a constitutively phosphorylated state (CP) [16]. The
mutagenic primers are: S102A: 59-CGGAAGAGGCTGGCT-
GATGCCATCGTG-39 (sense), 59-CACGATGGCATCAGC-
CAGCCTCTTCCG–39 (antisense); S1003A: 59-CATAGGA-
CATTTGCATACCCGGGAATG-39(sense),59-CATTCCCGGG
TATGCAAATGTCCTATG-39 (antisense); S102E: 59-CGGAA-
GAGGCTGGAAGATTCCATCGTG-39 (sense), 59-CACGATG-
GAATCTTCCAGCCTCTTCCG-39 (antisense); S1003E: 59-
CATAGGACATTTGAATACCCGGGAATGGT-39 (sense), 59-
ACCATTCCCGGGTATTCAAATGTCCTATG-39 (antisense);
Mutagenic primers for other residues have been reported previously.
The positive clones were verified by DNA sequencing and for
expression.
Cell culture, transfection and RNA interference
3T3-L1 and RIP140 null adipocytes were maintained and
differentiated (8 day) by a differentiation cocktail that included
insulin, triiodothyronine, dexamethasone and isobutylmethyl-
xanthine as described earlier [43]. Transient transfection/ reconsti-
tution in RIP null adipocytes was as described earlier [12].
Quantitative determination of triglycerides (TG) was performed by
alkaline hydrolysis and measurement of glycerol released by the Free
Glycerol Determination Kit (Sigma). The TG level was normalized
to protein concentration. Nuclear and cytoplasmic fractions were
obtained as described previously [44] with some modifications.
Scrambled RNA and siRNAs for Nrip1 (encoding RIP140; 59-
GCUUCUUUCUUUAAUCUAATT-39/59-UUAGAUUAAAGA
AAGAAGCTT-39, SI02698759), Prkce (encoding PKCe;5 9-
GGCGGAACUCAAAGGCAAATT-39/59-UUUGCCUUUGAG
UUCCGCCAA-39, SI01388793) and Ywhab (encoding 14-3-3b;5 9-
CCCUGAAUGAAGAGUCUUATT-39/59-UAAGACUCUUCA
UUCAGGGTG-39, SI00212037), were from Qiagen. siRNAs for
Prmt1 (encoding PRMT1) were from Dharmacon [12]. RNAs were
introduced using DharmaFECT1 (T-2001-01, Dharmacon) or
HiPerfect (no. 301704, Qiagen). Silencing was assessed by western
blots at 72 hs.
Chemicals and treatments
All treatments were done in Dulbecco’s modified Eagle’s
medium containing DCC serum. Leptomycin B (18 nM), a
selective inhibitor of CRM1, and adenosine 2,3 dialdehyde, a
global methyl transferase inhibitor (10 mM) (Sigma), were added
for 4 h before harvesting the cells. Activators/inhibitors (calbio-
chem) of kinases, Sphingosine-1-phosphate (MAPK/ERK activa-
tor, 1 mM), Phorbol-12-myristate-13-acetate (PKC activator,
Nuclear-Cytoplasmic of RIP140
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inhibitor, 50 nM) were added for 4 h unless otherwise stated.
Immunoprecipitation and western blotting
Cell extracts were suspended in 250 ml of immunoprecipitation
buffer (150 mM NaCl,50 mM Tris-HCl (pH 8.0), 1 mM EDTA,
0.2% (v/v) Nonidet P40, 2 mM PMSF, 0.1% (w/v) SDS and a
protease-inhibitor cocktail. Protein extracts (200 mg) were incu-
bated with antibodies to RIP140, 14-3-3, or PRMT1 overnight at
4uC, and precipitated with protein G–agarose beads for 1–2 hs.
Western blots were performed as described [45]. Antibodies used
were, RIP140 [46], PKCe (sc-214, Santa Cruz), 14-3-3b (sc-629,
Santa Cruz), PRMT1 (sc-13393, Santa Cruz), RAR-b2 [12] and
methylated-arginine specific antibody (ab412, Abcam). Reduced
protein inputs were used for ectopic expression of RIP140 to avoid
saturation.
Immunohistochemical staining
For immunohistochemical staining, 3T3-L1 cells were differen-
tiated for 8 days by differentiation protocol. Cells were treated as
indicated in serum-free media. After 2 h, cells were fixed by a 4%
fixation solution and permeated by a permeation buffer for 10 and
5 minute on ice, respectively. After permeation, cells were blocked
by a blocking buffer (1% BSA and 0.1% Tween-20 in PBS) for
30 minute and then incubated with the primary antibody
overnight in 4uC. After washing three times, cells were incubated
with the secondary antibody for 2 h in room temperature. Images
were acquired using Olympus fluoview 1000. The typical field
containing multiple cells of the unprocessed images were cropped
with a similar dimension for each image using the crop tool at
Adobe Photoshop. To determine the differential sub-cellular
distribution pattern of RIP140 constructs, many microscopic
fields of the images were randomly selected with the help of a
manipulator and the distribution pattern (nuclear, nuclear-
cytoplasm, and cytoplasmic) within cells were recorded. In
addition, the randomly selected fields were properly focused to
capture the images with the same setting and stored as digital
image files. The unprocessed images were retrieved for unbiased
cell counting. Cytoplasmic intensity .20% of total intensity was
counted as N/C.
Analysis of Biological (Trans-repressive) Activity of RIP140
The technique for culturing COS-1 cells, transfection experi-
ments, and luciferase and lacZ assay were as described previously
[12]. Cells were transiently transfected with a mixture of pBD-
GAL4-RIP140 full length/N-terminal, wild-type (WT)/mutant
(Mut) (0.1 mg) or pBD-GAL4 (0.1 mg), GAL4- tk-luciferase
(0.5 mg) reporter, and a CMV-lacZ internal control (0.05 mg).
20 h post-transfection, cultures were fed with fresh medium
containing dextran charcoal (DCC)-treated serum and treated for
4 h with either MAPK or PKC activator. 24 h post-transfection,
total cell extracts were collected and tested for luciferase and lacZ
activity. The fold relative luciferase activity was calculated by
normalizing each relative luciferase units (RLU) activity to the
RLU of pBDGAL4. Reported values were the averages of three
experiments with triplicate measurements.
GST pull-down assays
Various GST–RIP140 wt/mt constructs [full-length (amino
acids 1–1161), were expressed and purified from E. coli and
bound to GST beads as described earlier [45]. Washed beads were
incubated with in vitro-transcribed and translated (Promega) [
35S]
Met-labeled 14-3-3. Specifically bound proteins were resolved by
SDS-PAGE and detected with a Phosphorimager. In vitro
transcription-coupled translation product subjected to SDS-PAGE
constituted TNT input (50%). Equal volumes subjected to SDS-
PAGE and stained with Coomassie blue constituted the GST
input.
In vitro phosphorylation assay
PKCe was partially purified from adipocyte whole cell extracts
and nuclear and cytoplasmic fractions by immunoprecipitation. In
vitro phosphoylation of bacterial purified wt/mt RIP140 by PKCe
was carried out as described [47].
Purification and Mass Spectrometric Analysis of RIP140
To identify the phosphorylation sites on RIP140, we expressed
the His-tagged RIP140 in insect cells as a eukaryotic host for
mammalian protein expression. The protein was purified by
affinity column over Talon resin with 95% homogeneity. The
details of the procedure for RIP140 purification was described
previously [13]. The purified RIP140 was subjected to tryptic
digestion, and LC-ESI-MS/MS analysis was conducted as
described [13].
Supporting Information
Figure S1 Screening of PKC responsive domains and residues of
RIP140 with regards to its trans-repressive activity. (A) PKC
activation reduced transrepression mediated by the N- and C-
terminal, but not the central, domain of RIP140. (B) Ser-102 (in
the N-terminal domain) and Ser-1003 (in the C-terminal domain)
were responsive to PKC modulation. PKC activator: PMA.
Found at: doi:10.1371/journal.pone.0002658.s001 (0.23 MB TIF)
Figure S2 Mapping of phosphorylation sites on Ser-102 and Ser-
104 on mouse RIP140 purified from insect cultures, by LC-ESI-
MS/MS analysis. The total ion chromatogram (LC-MS) of tryptic
digests of RIP140 showed three modified peptides spanning amino
acids 101–111aa (101LSDSIVNLNVK111) (A), 101–112 aa
(101LSDSIVNLNVKK112) (B), and 100–111 aa (100RL
SDSIVNLNVK111) (C) contained both Ser-102 and Ser-104 (bold
letter). The modified peptide spanning 100–111 (C, top) and 101–
112 (B, top) appeared as doubly charged ions, respectively at
719.36 m/z (mol. mass 1436.72) and 705.35 m/z (mol. mass
140.72), while the peptide (101–111 aa) appeared as a triply charged
ion at 641.31 m/z (mol. mass 1280.63). The precursor mass of each
ion from the modified peptide showed +80 Da mass shift as
compared to the each doubly charged peptide ion of the
corresponding unmodified peptide 100–111 aa (679.37 m/z, mol.
mass 1356.76 Da) (C, bottom), 101–111 aa (601.33 m/z, mol. mass
1200.66 Da) (A, bottom) and 101–112 aa (665.36 m/z, mol. mass
1328.75 Da) (B, bottom). This indicated that each peptide is
modified by a mono-phosphorylation site. Previously, by MS/MS
analysis of the precursor ion of the modified peptide 100–111 aa (C,
top), we have reported the assignments of phosphorylation site at
Ser-104 (Huq et al, 2005). However, careful analysis of all three
peptide ions revealed that each peptide actually contained two
species of modification by a single phosphorylation site. One species
contained the modification site at Ser-102 (S1 site) and the other
species contained the modification site at Ser-104 (S2 site). Here, we
ascertained the assignments of both sides by careful analysis of the
MS/MS spectra of the above three peptides. In the MS/MS
spectrum of the modified peptide spanning 101–111 aa (A, top) two
species of fragment ions (b or y ions) were shown to consider
phosphorylation site either at Ser-102 (S1 site) or Ser-104 (S2 site).
The spectra shows consecutive b ions due beta-elimination H3PO4
as b2-P (s1), b3-P (s1), b4-P (s1/s2) at 183.11 m/z, 298.13 m/z,
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Ser-102. The spectrum also showed relatively low intense a2+P( s 1 )
peak at 253.09 m/z having the intact phosphate moiety. This
provided significant confidence to assign the phosphorylation site at
Ser-102. In addition, the intense y9-NH3 ion at 984.53 m/z
corresponded to the unmodified peptide. This further confirmed the
modification at Ser-102. On the other hand, the spectra showed b2
(s2) and b3 (s2) ions, respectively at 201.12 m/z and 316.15 m/z,
which corresponded to unmodified peptide. This suggested some
species of the peptide were not modified at Ser-102. However, the
spectra showed b4-P, b5-P, b8-P and b10-P ions at 385.17 m/z,
498.25 m/z, 868.52 m/z and 1070.58 m/z, respectively due to
possible beta-elimination of H3PO4 from Ser-104, suggesting the
possible location of the phosphorylation site in other species of the
peptide (101–111 aa) was at Ser-104. The MS/MS spectrum of
tryptic missed cleaved peptide (101–112 aa) (B, top) showed similar
fragmentationpatternasthatoftrypticpeptidespanning101–111aa
(A, top). However, the a2+P (s1) ions at 253.09 m/z were more
intense as compared to that of peptide spanning 101–111 aa (A, top),
further suggesting the phosphorylation site at Ser-102. Finally, MS/
MS spectrum of the othermissed cleaved modified peptide (100–111
aa) (C,top),showedintenseofb4ion at 472.25 m/zcorresponded to
the unmodified peptide, suggesting no phosphorylation at Ser-102.
However, the doubly charged y12 ion at 719.37 m/z contained the
intact phosphate moiety. Thus the modification site in this peptide
was assigned to Ser-104 as reported previously (Huq et al, 2005).
Takentogether,theanalysisoftheabovethreepeptidesrevealedthat
both Ser-102 and Ser-140 are modified by mono-phosphorylation
on RIP140.
Found at: doi:10.1371/journal.pone.0002658.s002 (1.84 MB TIF)
Figure S3 PKCe distribution and functionality in differentiated
adipocytes. In vitro phosphorylation of bacterial purified RIP140
by partially purified endogenous PKCe from nuclear and
cytoplasmic fraction.
Found at: doi:10.1371/journal.pone.0002658.s003 (0.30 MB TIF)
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